Back

Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Novelties in amyloid cardiomyopathy Clinical HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Vincenzo Castiglione

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

Photo
Associate Professor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)

3 More presentations in this session

Presentation thumbnail
Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy.
Doctor M. Maccallini (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights
Doctor M. Perotto (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio in amyloid cardiomyopathy
Doctor M. Maccallini (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Novelties in amyloid cardiomyopathy
Video

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources